June 05, 2006 16:00 ET

Ceapro named on Profit 100 list of Canada's fastest-growing companies

EDMONTON, June 5 - Ceapro Inc. (TSX VENTURE:CZO) has been named one of
Canada's Fastest-Growing Companies as part of the 18th annual PROFIT 100, the
definitive ranking of Canada's best and brightest growth firms. Ceapro's
position was 173 in the top 200 companies as listed in the PROFIT 100 and Next
100 rankings.

Dr. Mark Redmond, Ceapro's President and CEO, credits the company's
ranking in the Profit 100 to fast revenue growth, primarily in the sales of
natural, active ingredients coupled with unique technical abilities recognized
and sought after by our international partners. "Our team's expertise has
enabled the Company to advance its corporate strategy and build a strong
product and technology pipeline," stated Dr. Redmond. "Ceapro has positioned
itself as a recognized leader in our field of biotechnology and we look
forward to the Company's continued growth and future successes."

Ranking Canada's Fastest-Growing Companies by five-year revenue growth,
the PROFIT 100 profiles the country's most successful growth companies.
Published in the June issue of PROFIT and online at PROFITguide.com, the
PROFIT 100 is Canada's largest annual celebration of entrepreneurial
achievement. "The PROFIT 100 are role models for anyone who wants to seize
today's best business opportunities," says Ian Portsmouth, editor of PROFIT.
"By differentiating their products and applying creative management thinking,
Canada's Fastest-Growing Companies are outpacing the competition at home and

About PROFIT Magazine

PROFIT: Your Guide to Business Success, offers news, strategies, tips,
interviews and other resources to entrepreneurs leading Canada's growing
companies. Each year PROFIT - which currently reaches 373,000 readers
nationally - hosts a number of events that bring together business leaders in
the fast-growth segment and champions the interest of those leaders. PROFIT
was founded in 1992 as Canada's first national magazine geared to

About Ceapro Inc.

Ceapro Inc is a Canadian growth stage biotechnology company. Ceapro's
core technology is the extraction of functional, active ingredients from
plants and other renewable resources. We add further value to our extracts by
manufacturing medical and therapeutic products, and by supporting the use of
our extracts in products for human and animal health. We have also introduced
health and wellness services employing our CeaProve® diagnostic technology.
Ceapro shares trade on the Canadian TSX Venture Exchange under the symbol CZO.
To learn more about Ceapro, visit our website at www.ceapro.com. Shares
Outstanding: 37,098,670, Recent Close: $0.30.

The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or the accuracy of this news release.

This release may contain forward-looking statements. Various factors
could cause actual results to differ materially from those projected in
forward-looking statements. Although the Company believes that the
forward-looking statements contained herein are reasonable, it can give no
assurance that the Company's expectations are correct. All forward-looking
statements are expressly qualified in their entirety by this cautionary

Contact Information

  • Dr. Mark Redmond, President and CEO, Ceapro
    Inc., Telephone: (780) 421-4555